Physician profile
Randall E Little
NPI 1205807385
$1,763.11
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $229 · 2021: $220 · 2022: $634 · 2023: $209 · 2024: $20.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $384.32 | 2019-2022 | |
| Pfizer INC. | $227.70 | 2020-2024 | |
| Astellas Pharma US INC | $214.66 | 2019-2021 | |
| Medtronic, INC. | $184.10 | 2022 | |
| Amgen INC. | $135.60 | 2020-2022 | |
| Actelion Pharmaceuticals US, INC. | $98.38 | 2020-2023 | Opsumit, Uptravi |
| Novo Nordisk INC | $90.96 | 2022-2023 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $66.82 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $62.75 | 2020-2022 | |
| Roche Diagnostics Corporation | $50.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $41.16 | 2019-2022 | |
| Boston Scientific Corporation | $34.67 | 2023 | |
| Esperion Therapeutics, INC. | $29.40 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $27.16 | 2021-2022 | |
| Abbott Laboratories | $24.53 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $23.38 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.65 | 2023 | Jardiance |
| Daiichi Sankyo INC. | $17.76 | 2020 | |
| Preventice Services, LLC | $15.79 | 2020 | |
| Irhythm Technologies, INC. | $14.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Little listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.